News

There is a critical need to find cures for incurable pediatric brain tumors through accelerated and focused research. That's why Miles for Hope (MFH) is hosting its Moving Towards a Cure® 5K Brain Tumor Awareness Run/Walk at 9:00 a.m. Saturday, July 21, at Riverside Park in New York City. A large portion of the event proceeds will provide funding for research by Weill Cornell Medical College's Children's Brain Tumor Project at the Weill Cornell Pediatric Brain and Spine Center.

Awards, honors, prizes and achievements for the weeks of July 6 - July 20.

Dean Laurie H. Glimcher speaks with Dr. Michael Stewart, an ear, nose and throat clinician who has just been appointed vice dean of Weill Cornell. In this newly established position, Dr. Stewart will work to enhance the academic and clinical missions of the Medical College.

Researchers at Weill Cornell Medical College were awarded a $6.5 million grant from the National Heart, Lung, and Blood Institute for a five-year investigation into metabolic changes occurring within airway epithelial cells in the lungs of chronic obstructive pulmonary disease (COPD) patients caused by cigarette smoking. In addition, researchers aim to identify which cigarette smokers are at highest risk of developing COPD as well as novel biomarkers to assist in the development of new therapeutic treatments for the disease.

The Lymphoma Research Foundation (LRF) has announced the election of John P. Leonard, MD, as the chairman of its Scientific Advisory Board (SAB). Dr. Leonard is the associate dean for clinical research at Weill Cornell Medical College, vice chairman for clinical research in the Department of Medicine, and the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology. He also serves as clinical director of the Weill Cornell Center for Lymphoma and Myeloma, attending physician at NewYork-Presbyterian/Weill Cornell Medical Center, and is associate director for Clinical Research of the Weill Cornell Cancer Center.

Weill Cornell Medical College and AstraZeneca today announced a first of its kind research alliance that brings four leading academic research laboratories together with AstraZeneca to study a major risk factor for Alzheimer's disease, the apolipoprotein E4 genotype (ApoE).

A team of researchers from Weill Cornell Medical College and The Rockefeller University have pioneered a new method for determining exactly how a drug works in human cells, including identifying a drug's mechanism of action and its molecular targets.

Weill Cornell Medical College has appointed Dr. Michael G. Stewart to the new role of vice dean for the Medical College and Dr. John P. Leonard as the new associate dean for clinical research.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the first and only hospital in the five boroughs of New York City to offer women with early stage breast cancer INTRABEAM radiotherapy, an innovative radiation treatment delivered in a single dose at the time of surgery.

Awards, honors, prizes and achievements for the week of June 29 - July 6.

If discovery of new antibiotics continue to falter while resistance to those currently in clinical use spread, society will soon lack effective remedies to cure infections. But it doesn't have to be that way.

Dean Laurie H. Glimcher speaks with Weill Cornell researcher Dr. Anthony Sauve, who recently discovered that high doses of a vitamin normally found in milk can have enormous implications in the fight against obesity.

The Weill Cornell Medical College community recognized three of its own June 14 for exemplary leadership in promoting diversity at the Medical College.

Awards, honors, prizes and achievements for the week of June 22 - June 29.

Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.

"NY Med," the eight-part television series from ABC News, chronicles the 24/7 drama of NewYork-Presbyterian Hospital in New York City. The documentary from the award winning producers of "Hopkins" and "Boston Med," scheduled to premiere on Tuesday, July 10 at 10:00 PM/ET on ABC, takes a raw and intimate look at life inside the most famous hospital in America's largest city.

Seven pharmaceutical companies and four research institutions including Weill Cornell Medical College, working with the Bill & Melinda Gates Foundation, have launched an innovative partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB).

An interdisciplinary team of researchers from Weill Cornell Medical College and the Visiting Nurse Service of New York are investigating how patient health is impacted by communication between visiting nurses and physicians.